$1.75
-0.08-4.37%
Pre-Market: Nov 11, 7:40 AM EDT
Comments
Loading...
XTL Biopharmaceuticals (NASDAQ:XTLB) Stock, Earnings Estimates, EPS, And Revenue
XTL Biopharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 20
EPS
$0.001
Quarterly Revenue
$0K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of XTL Biopharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
XTL Biopharmaceuticals (XTLB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
XTL Biopharmaceuticals (XTLB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is XTL Biopharmaceuticals (NASDAQ:XTLB) reporting earnings?
XTL Biopharmaceuticals (XTLB) is scheduled to report earnings on February 20, 2025. The last reported earnings were for reported on May 20, 2024 for Q1.
What were the latest earnings per share (EPS) for XTL Biopharmaceuticals (NASDAQ:XTLB)?
The Actual EPS was $0.00, which beat the estimate of $0.00.
What were XTL Biopharmaceuticals’s (NASDAQ:XTLB) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.